Use: Labeled indications
- INDICATIONS & USAGE Cephalexin tablets are indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Respiratory tract infections caused by susceptible…
Full indications and usage US FDA label
INDICATIONS & USAGE Cephalexin tablets are indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Respiratory tract infections caused by susceptible isolates of Streptococcus pneumoniae and Streptococcus pyogenes Otitis media due to susceptible isolates of Streptococcu.. pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Moraxella Catarrhalis. Skin and skin structure infections caused by susceptible isolates of the following Gram-positive bacteria: Staphylococcus aureus, and Streptococcus pyogenes Bone infections caused by susceptible isolates of Staphylococcus aureus and Proteus Mirabilis Genitourinary tract infections, including acute prostatitis, caused by susceptible isolates of Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniare To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin tablets and other antibacterial drugs, cephalexin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Contraindications
- Known allergy to cephalexin or other cephalosporins
Contraindications (US label) US FDA label
CONTRAINDICATION Cephalexin tablets are contraindicated in patients with known allergy to cephalexin or other members of the cephalosporin class of antibacterial drugs.
Dosing: Adult
- Adults and children 15 years or older: 250 mg every 6 hours or 500 mg every 12 hours for 7 to 14 days
- Severe infections: Up to 4 g/day in 2 to 4 divided doses
- CrCl below 60 mL/min: 30–59: max 1 g/day; 15–29: 250 mg every 8–12 hours; 5–14: 250 mg every 24 hours; 1–4: 250 mg every 48–60 hours
Dosage and administration (US label) US FDA label
DOSAGE & ADMINISTRATION Cephalexin tablets are administered orally. Adults and Pediatric Patients at Least 15 Years of Age The usual dose is 250 mg every 6 hours but a dose of 500 mg every 12 hours may be administered. Treatment is administered for 7 to 14 days. For more severe infections larger doses of oral cephalexin may be needed, up to 4 grams in two to four equally divided doses.
Pediatric Patients (over 1 year of age) The recommended total daily dose of oral cephalexin for pediatric patients is 25 to 50 mg/kg in equally divided doses for 7 to 14 days. In the treatment of β-hemolytic streptococcal infections, duration of at least 10 days is recommended. In severe infections, a total daily dose of 50 to 100 mg/kg may be administered in equally divided doses.
In the treatment of otitis media, the recommended daily dose is 75 to 100 mg/kg/day in equally divided doses. Dosage adjustments in Adults and Pediatric Patients at Least 15 years of Age with Renal Impairment Administer the following dosing regimens for cephalexin tablets to patients with renal impairment [see PRECAUTIONS].
Table 1. Recommended Dose Regimen for Patients with Renal Impairment Renal function Dose regimen recommendation Creatinine clearance >60 mL/min No dose adjustment Creatinine clearance 30 to 59 mL/min No dose adjustment; maximum daily dose should not exceed 1 g Creatinine clearance 15 to 29 mL/min 250 mg, every 8 hours or every 12 hours Creatinine clearance 5 to 14 mL/min not yet on dialysis* 250 mg, every 24 hours Creatinine clearance 1 to 4 mL/min not yet on dialysis* 250 mg, every 48 hours or every 60 hours *There is insufficient information to make dose adjustment recommendations in patients on hemodialysis.
Dosing: Altered kidney function
Cefalexin (cephalexin) is over 90% excreted unchanged in urine within 8 hours. The US label (adults and children 15 years or older) needs no dose change above a creatinine clearance (CrCl) of 60 mL/min, caps the daily dose at 1 g at 30–59, and lowers it to 250 mg at longer intervals below 30. The label has too little information to recommend a dose on hemodialysis.
Kidney function measure: Label uses CrCl (mL/min); bands at 60, 30, 15, 5 and 1. Applies to adults and children at least 15 years old.
Show full dosing details
- CrCl ≥60 mL/min
- CrCl above 60: no dose change (label).
- CrCl 30–59 mL/min
- CrCl 30–59: no dose change, but maximum daily dose 1 g (label).
- CrCl 15–29 mL/min
- CrCl 15–29: 250 mg every 8 or 12 hours (label).
- CrCl <15 mL/min (not on dialysis)
- CrCl 5–14, not on dialysis: 250 mg every 24 hours. CrCl 1–4, not on dialysis: 250 mg every 48 or 60 hours (label).
- Hemodialysis (intermittent)
- Insufficient information to recommend a dose on hemodialysis (label). Specialist input.
- Peritoneal dialysis
- No peritoneal dialysis dosing in label. Specialist input.
- CRRT
- Not in label; the cited CRRT review (Li 2020) gives no regimen for this drug. Specialist input.
- Dialyzable? Not established: the label says hemodialysis or peritoneal dialysis has not been shown to help in overdose. Protein binding 10% to 15%.
- Monitoring CrCl for dose; seizures with unadjusted doses in kidney impairment (label precautions); metformin levels if coadministered; diarrhea (CDAD).
Children (kidney dosing)
Show full dosing details
- eGFR ≥60
- Usual weight-based dose (label).
- eGFR 30–59
- Children 15 years or older: use the adult CrCl table. Under 15 years: no kidney dosing in label; specialist input.
- eGFR 15–29
- Children 15 years or older: use the adult CrCl table. Under 15 years: no kidney dosing in label; specialist input.
- eGFR <15 (not on dialysis)
- Children 15 years or older: use the adult CrCl table. Under 15 years: no kidney dosing in label; specialist input.
- Hemodialysis (intermittent)
- No pediatric dialysis dosing in label. Specialist input.
- Peritoneal dialysis
- No pediatric dialysis dosing in label. Specialist input.
- CRRT
- No pediatric dialysis dosing in label. Specialist input.
Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.
renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.
US label text: Renal impairment US FDA label
Renal Impairment Administer the following dosing regimens for cephalexin tablets to patients with renal impairment [see PRECAUTIONS]. Table 1. Recommended Dose Regimen for Patients with Renal Impairment Renal function Dose regimen recommendation Creatinine clearance >60 mL/min No dose adjustment Creatinine clearance 30 to 59 mL/min No dose adjustment; maximum daily dose should not exceed 1 g Creatinine clearance 15 to 29 mL/min 250 mg, every 8 hours or every 12 hours Creatinine clearance 5 to 14 mL/min not yet on dialysis* 250 mg, every 24 hours Creatinine clearance 1 to 4 mL/min not yet on dialysis* 250 mg, every 48 hours or every 60 hours *There is insufficient information to make dose adjustment recommendations in patients on hemodialysis.
Dosing: Pediatric
- Approved ages
- Over 1 year (label).
- Usual dose
- 25 to 50 mg/kg/day in divided doses (severe infections 50 to 100 mg/kg/day; otitis media 75 to 100 mg/kg/day) (label).
- Maximum dose
- Adult maximum 4 g/day (label).
Kidney dosing in children: see Dosing: Altered kidney function.
renalcarematters.com, reviewedPediatric use (US label) US FDA label
PEDIATRIC USE The safety and effectiveness of cephalexin tablets in pediatric patients was established in clinical trials for the dosages described in the dosage and administration section [see DOSAGE AND ADMINISTRATION].
Dosing: Older adult
Geriatric use (US label) US FDA label
GERIATRIC USE Of the 701 subjects in 3 published clinical studies of cephalexin, 433 (62%) were 65 and over. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients.
This drug is substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection.
Dosage forms
Philippines
- Powder for suspension: 100 mg per mL, 100 mg/mL, 125 mg/5 mL, 125 mg/mL, 250 mg/5 mL
- Capsule: 250 mg, 500 mg
- Powder for oral suspension: 100 mg/mL, 125 mg/5 mL, 250 mg/5 mL
- Granule for suspension: 100 mg/mL, 250 mg/5 mL
- Powder for suspension for oral drops: 100 mg/mL
- Granule for oral suspension: 125 mg/5 mL, 250 mg/5 mL
Registered products in the Philippines
249 products registered with the Food and Drug Administration (FDA) Philippines list Cefalexin as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: Cephalexin (2 products). Products registered under these spellings are included in the table and marked.
All registered products249
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AirexCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY19608 | Feb 12, 2027 | |
AirexCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY29937 | Sep 1, 2029 | |
AirexCefalexin (as Monohydrate) | 250 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY22453 | Jan 16, 2027 | |
AirexCefalexin (as monohydrate) | 250 mg/5 ml Granules for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY17862 | Aug 14, 2031 | |
AirexCefalexin (as monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY17889 | Mar 12, 2031 | |
BandaxCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Bottle x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-6874 | Jun 23, 2027 | |
BandaxCefalexin (as monohydrate) | 250 mg/5 mL Granules for SuspensionTransparent HDPE Plastic Bottle x 60 mL, with White Plastic Cap and Transparent Polypropylene Plastic Cap (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-6899 | Aug 3, 2031 | |
BandaxCefalexin (as Monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-8491 | Apr 30, 2027 | |
BarcefCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)15mL Amber Glass Bottle (10mL net content) with medicine dropper (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Seammed Pharma | DRP-324-02 | Jan 28, 2030 | |
BarcefCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Seammed Pharma | DRP-098-05 | Feb 15, 2037 | |
BarcefCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Seammed Pharma | DRP-096-05 | Nov 18, 2029 | |
BarcefCefalexin (as monohydrate) | 500mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | Seammed Pharma | DRP-231-03 | Jul 31, 2031 | |
Brulexin-500Cefalexin (as monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10’s (Box of 100’s) | Rx | Brawn Laboratories LimitedIndia | Importer: Ambica International Corporation | DRP-4436 | May 23, 2028 | |
CanelinCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension10 mL in 15 mL Boston Round Amber Glass Bottle Box of 1's; 15 mL in 30 mL Boston Round Amber Glass Bottle Box of 1's | Rx | LIFESQUARE LABORATORIES INC.Philippines | — | DRP-1225 | Jan 19, 2030 | |
CanelinCefalexin | 250 mg/ 5 mL Powder for Suspension120 mL Capacity Amber Glass Bottle x 60 mL, 90 mL, and 105 mL net content (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Cavite | — | DRP-735 | May 21, 2031 | |
CanelinCefalexin (as Monohydrate) | 500 mg CapsuleAluminum Foil Strip x 4's Box of 100's | Rx | LIFESQUARE LABORATORIES INC.Philippines | — | DRP-736 | Jan 17, 2030 | |
CanexilCefalexin (as Monohydrate) | 100 mg/mL Powder For Suspension10 mL in 15 mL Boston Round Amber Glass Bottle (Box of 1’s); 15 mL in 30 mL Boston Round Amber Glass Bottle (Box of 1’s) | Rx | LIFESQUARE LABORATORIES INC.Philippines | ALMAN PHARMACEUTICALS, INC. | DRP-1225-07 | Jan 19, 2030 | |
CanexilCefalexin (as Monohydrate) | 500 mg CapsuleAluminum Foil Strip x 4’s (Box of 100’s) | Rx | Lifesquare Laboratories Inc.Philippines | Alman Pharmaceuticals, Inc. | DRP-736-06 | Jan 17, 2030 | |
Cefa-RedCefalexin (as Monohydrate) | 500 mg CapsuleClear PVC/Alu Foil Blister Pack (Box of 100's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Red Drug Pharmaceutical Inc. | DRP-132-10 | Aug 4, 2027 | |
CefacureCefalexin (as monohydrate) | 500 mg CapsuleAlu /Clear PVC blister pack x 10's (Box of 50's and 100's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Jaac Healthline Marketing | DRP-16453-03 | Apr 3, 2027 | |
CefadenCefalexin | 500 mg CapsuleAlu-PVC Blister x 10's (Box of 100's) | Rx | NGB Laboratories Pvt. Ltd.India | Cyden Medicale Trading Inc.Importer: AMB HK Enterprises Inc. | DRP-11694-01 | Jun 9, 2028 | |
CefafirstCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)10 mL in 15 mL Amber Bottle (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Firstmed Theraconcept Inc. | DRP-1542-05 | Nov 21, 2031 | |
CefagenCefalexin (as monohydrate) | 250 mg/5 mL Powder for Oral Suspension (Strawberry-Raspberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Quad-Gen PharmaceuticalsTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-1547-03 | Jun 24, 2027 | |
CefalareCefalexin (AS Monohydrate) | 250 mg / 5 mL Powder for Suspension60 mL Amber Bottle (Box of 1's); 120 mL Amber Bottle (60 mL content) (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Care First Trading | DRP-10663 | Jun 27, 2031 | |
CefalexCefalexin (as Monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Sapphire Lifesciences Pvt. Ltd.India | 777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc. | DRP-4856-01 | Oct 24, 2028 | |
CefalinCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Bottle x 10 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY17641 | Feb 27, 2027 | |
CefalinCefalexin (as monohydrate) | 125 mg/5 mL Powder for Oral SuspensionAmber Glass Bottle with Aluminum Pilfer Proof Cap x 60 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DRP-9504 | Aug 31, 2031 | |
CefalinCefalexin (as monohydrate) | 250 mg CapsuleAluminum Flex Foil Strip x 10's (Box of 50's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-X5549 | Jan 22, 2028 | |
CefalinCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionAmber Bottle x 60 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY17642 | Feb 27, 2027 | |
CefalinCefalexin (as monohydrate) | 500 mg capsuleAluminum Foil Strip x 10's (Box of 50's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: UNILAB, Inc. | DR‐X5548 | May 26, 2027 | |
CefamaxCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)10 mL in 15 mL Amber Bottle (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | TGIF Pharmaceutical Trading Inc. | DRP-1542-06 | Nov 21, 2031 | |
CefamaxCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension (Strawberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | TGIF Pharmaceutical Trading Inc. | DRP-1426-05 | Feb 5, 2027 | |
CefamaxCefalexin (as monohydrate) | 500 mg CapsuleClear PVC/Alu Foil Blister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | TGIF Pharmaceutical Trading | DRP-132-05 | Aug 4, 2027 | |
CefamedCefalexin (as monohydrate) | 250 mg/5 mL Powder for Oral Suspension (Strawberry-Raspberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Thymed EnterprisesTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-1547-01 | Jun 24, 2027 | |
CefamedCefalexin (as monohydrate) | 500 mg CapsuleAlu/Red PVC Blister Pack x 10's Box of 100's | Rx | Lloyd Laboratories, Inc.Philippines | Thymed EnterprisesTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-1548-01 | Aug 25, 2027 | |
CefarapCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension for Oral DropsBoston Round Glass Bottle x 15mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-12392-01 | Jul 21, 2027 | |
CefarapCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-12407-01 | Jul 21, 2027 | |
CEFARAPCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-12408-01 | Jul 21, 2027 | |
CefarapCefalexin | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10’s (Box of 50’s and 100’s) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-16453-01 | Apr 3, 2027 | |
CefathixCefalexin (as monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Medico Remedies LimitedIndia | Medethix, Inc. | DRP-15810 | Sep 17, 2031 | |
CefatreneCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension (Strawberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Aisec Farma Corporation | DRP-1426-02 | Feb 5, 2027 | |
CefavitCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)15mL Amber Glass Bottle (10mL net content) with medicine dropper (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Lumar Pharmaceutical Laboratory, Inc. | DRP-324-06 | Jan 28, 2030 | |
CefavitCefalexin (as monohydrate) | 125mg/5mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Lumar Pharmaceutical Laboratory, Inc. | DRP-098-10 | Feb 1, 2030 | |
CefavitCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Lumar Pharmaceutical Laboratory, Inc. | DRP-096-08 | Nov 18, 2029 | |
CefavitCefalexin (as monohydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | Lumar Pharmaceutical Laboratory, Inc. | DRP-231-07 | Jul 26, 2031 | |
CefaxCefalexin (as monohydrate) | 100 mg/mL Powder for Oral Suspension (Oral Drops)Amber Glass Bottle x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: D.B. Manix International, Inc. | DR-XY22121-B | Oct 13, 2027 | |
CefaxCefalexin (as monohydrate) | 250 mg/5 mL Powder for Suspension | Rx | Lloyd Laboratories, Inc. | Altomed Pharmaceuticals, Inc.Trader: D.B. Manix International, Inc. | DR-XY17186-B | Jan 24, 2027 | |
CefaxCefalexin (as monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Bulacan | Altomed Pharmaceuticals, Inc.Trader: D.B. Manix International, Inc. | DR-XY16608 | Jul 12, 2037 | |
CefaxanCefalexin | 500 mg CapsuleAlu/PVC Blister Pack x 10'x (Box of 100's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | AMB HK Enterprises Inc. | DRP-18218 | Jun 2, 2031 | |
CefexilCefalexin (As Monohydrate) | 100 mg / mL Powder For Suspension (Oral Drops)Amber Glass Bottle x 10 mL (Net Content) with Plastic Dropper (Box of 1's) | Rx | J.M. Tolmann LaboratoriesPhilippines | Marti-Lian Pharma Link | DRP-130-06 | May 30, 2027 | |
CefexilCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension (Strawberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Marti-Lian Pharma Link | DRP-1426-08 | Feb 5, 2032 | |
CefexilCefalexin (as monohydrate) | 500 mg CapsuleClear PVC/Alu Foil Blister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Mart-Lian Pharma Link | DRP-132-09 | Aug 4, 2027 | |
CefledCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Oral SuspensionRound Boston Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Sapphire Lifesciences Pvt. Ltd.India | 777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc. | DRP-8387-01 | May 19, 2027 | |
CeflexCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionAmber glass bottle x 60 mL (Box of 1's) | Rx | Drugmakers Laboratories Inc.Philippines | — | DRP-5265 | Feb 9, 2037 | |
CeflinCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension10 mL in 15 mL Boston Round Amber Glass Bottle Box of 1’s; 15 mL in 30 mL Boston Round Amber Glass Bottle Box of 1’s | Rx | Lifesquare Laboratories, Inc.Philippines | Novomed Inc. | DRP-1225-06 | Jan 19, 2030 | |
CeflinCefalexin (as Monohydrate) | 500 mg CapsuleAluminum Foil Strip x 4's (Box of 100's) | Rx | LIFESQUARE LABORATORIES INC.Philippines | NOVOMED INC. | DRP-736-04 | Jan 17, 2030 | |
CelomaxCefalexin (as monohydrate) | 250 mg/ 5 mL Powder for SuspensionPlastic Amber Bottle x 60mL (Box of 1's) | Rx | Flamingo Pharmaceuticals Ltd.India | Nutramedica Inc.Importer: Hexagon Pharmaceuticals | DRP-459-02 | Jan 3, 2028 | |
CeloxoneCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Boston Round Bottle x 10 mL (net content) in 15 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Nutramedica Inc.Trader: Euro-Health Care Exponents, Inc. | DR-XY22647 | Mar 11, 2027 | |
CeloxoneCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension60 mL Amber Bottle with Secondary Box | Rx | Lloyd Laboratories, Inc.Philippines | Nutramedica Inc.Trader: Euro-Health Care Exponents, Inc. | DR-XY22507 | Jan 24, 2031 | |
CeloxoneCefalexin (as monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Nutramedica Inc.Trader: Euro-Health Care Exponents, Inc. | DRP-9995 | Aug 14, 2030 | |
CendalexCefalexin (as monohydrate) | 100 mg /mL Granules for Suspension (Oral Drops)Boston Round Amber Bottle x 10mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DRP-15260 | Jan 16, 2027 | |
CendalexCefalexin (as monohydrate) | 100 mg/mL Granules for Suspension (Oral Drops)Boston Round Amber Bottle x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DR-XY19994-B | Jan 16, 2027 | |
CendalexCefalexin | 125 mg / 5 mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DRP-15259 | Dec 27, 2027 | |
CendalexCefalexin (as Monohydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DR-XY19424 | Dec 27, 2027 | |
CendalexCefalexin (as monohydrate) | 250 mg / 5mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DRP-15238 | Dec 6, 2027 | |
CendalexCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DR-XY20605 | Dec 6, 2027 | |
CendalexCefalexin (as monohydrate) | 500 mg CapsuleFoil Strip of 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DR-XY21057 | Jul 11, 2027 | |
CendalexCefalexin (as monohydrate) | 500 mg CapsuleFoil Strip of 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DRP-15257 | Jul 11, 2027 | |
CephamCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL with plastic dropper Box of 1's | Rx | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DR-XY29842 | Aug 9, 2029 | |
CephamCefalexin (as Monohydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DR-XY29922 | Aug 30, 2029 | |
CephamCefalexin (as monohydrate) | 250 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-3557-01 | Jul 20, 2031 | |
CephamCefalexin (as monohydrate) | 250mg/5mL Powder for SuspensionAmber Glass Bottle x 60mL Box of 1's | Rx | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DR-XY29792 | Jul 26, 2029 | |
CephamCefalexin (as Monohydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DR-XY29793 | Jul 26, 2029 | |
CephoralCefalexin (as monohydrate) | 500 mg CapsuleClear PVC/Aluminum Blister Strip x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Primera Pharma, Corp. | DR-XY20277-B | Nov 11, 2031 | |
CeplegenCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension for Oral DropsBoston Round Glass Bottle x 15 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-12392-06 | Jul 21, 2027 | |
CeplegenCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-12407-06 | Jul 21, 2027 | |
CeplegenCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-12408-05 | Jul 21, 2027 | |
Ceplegen CapCefalexin (as Monohydrate) | 500 mg CapsuleAlu /Clear PVC blister pack x 10's (Box of 50's and 100's) | Rx | Azarias Pharmaceutical Laboratories, Inc.Philippines | Eba Generisch Trading Inc. | DRP-16453-02 | Apr 3, 2027 | |
CeplenextCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension for Oral DropsBoston round glass bottle x 15 mL Box of 1's | Rx | AZARIAS PHARMACEUTICAL LABORATORIES INC.Philippines | — | DR-XY45969 | Jul 21, 2027 | |
CeplenextCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension for Oral DropsBoston Round Glass Bottle x 15 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-12392 | Jul 21, 2027 | |
CeplenextCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionBoston round glass bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc..Philippines | — | DR-XY45967 | Jul 21, 2027 | |
CeplenextCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-12407 | Jul 21, 2027 | |
CeplenextCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionBoston round glass bottle x 60 mL Box of 1's | Rx | AZARIAS PHARMACEUTICAL LABORATORIES INC.Philippines | — | DR-XY45968 | Jul 21, 2027 | |
CeplenextCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-12408 | Jul 21, 2027 | |
CeplenextCefalexin (as monohydrate) | 500 mg CapsuleAlu /Clear PVC blister pack x 10's (Box of 50's and 100's) | Rx | Azarias Pharmaceutical Laboratories, Inc.Philippines | — | DRP-16453 | Apr 3, 2027 | |
CeplexCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension for Oral DropsBoston Round Glass Bottle x 15 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Konzept Convenience and Drug Store Corp. | DRP-12392-02 | Jul 21, 2027 | |
CeplexCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Konzept Convenience and Drug Store Corp. | DRP-12407-03 | Jul 21, 2027 | |
CeplexCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Konzept Convenience and Drug Store Corp. | DRP-12408-04 | Jul 21, 2027 | |
CidoxineCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Interhealthcare Pharmaceuticals Inc. | DR-XY17187-B | Nov 23, 2029 | |
CidoxineCefalexin (as monohydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | D and JB Pharma Medica Corp.Trader: Interhealthcare Pharmaceuticals Inc | DR-XY17727 | Apr 10, 2031 | |
Corfex 500Cefalexin (as Monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10’s (Box of 100’s) | Rx | Akums Drugs & Pharmaceuticals Ltd.India | Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-6225 | Jul 16, 2030 | |
Corfex-125Cefalexin | 125 mg/5 mL Powder for Oral SuspensionWhite HDPE Bottle with measuring cup x 30 mL (Box of 1’s) | Rx | Akums Drugs & Pharmaceuticals Ltd.India | Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-5483 | Sep 3, 2029 | |
DiacefCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Bottle x 10 mL and 15mL (Box of 1's) | Rx | Diamond Laboratories Inc.Philippines | Rilem Pharma Corp. | DRP-149 | Jul 21, 2031 | |
DiacefCefalexin (as monohydrate) | 125 mg / 5 mL Powder for Suspension (Strawberry Flavor)Amber Bottle x 60 mL (Box of 1's) | Rx | Diamond Laboratories, Inc.Philippines | — | DRP-201 | Feb 5, 2032 | |
DiacefCefalexin (as Monohydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Diamond Laboratories, Inc.Philippines | Rilem Pharma Corp. | DRP-7030 | Jul 4, 2031 | |
DiacefCefalexin (as monohydrate) | 250mg / 5mL Powder for SuspensionAmber Bottle x 60 mL (Box of 1's) | Rx | Diamond Laboratories, Inc.Philippines | Rilem Pharma Corp. | DRP-202 | Jan 17, 2032 | |
DiacefCefalexin (as monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10’s (Box of 100’s) | Rx | Diamond Laboratories Inc.Philippines | Rilem Pharma Corp. | DRP-150 | Jun 4, 2028 | |
EdexinCefalexin (as monohydrate) | 500 mg CapsulePaper Foil Strip x 4's (Box of 100's) | Rx | Sydenham Laboratories, Inc.Philippines | Trader: Scheeling, Inc. | DR-XY18419 | Jun 21, 2027 | |
EdexinCefalexin (as monohydrate) | 500 mg CapsuleBlister Pck x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Scheeling, Inc.Trader: Euro-Health Care Exponents, Inc. | DRP-9995-03 | Mar 7, 2031 | |
EdixinCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)15 mL Amber Glass Bottle (10 mL Net Content) with medicine dropper (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-324-05 | Jan 28, 2030 | |
EdixinCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-098-01 | Feb 1, 2030 | |
EdixinCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-096-01 | Nov 18, 2029 | |
EdixinCefalexin (as monohydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-231-01 | Jul 31, 2031 | |
Efoxin-250Cefalexin (as monohydrate) | 250 mg/5 mL Powder for Oral SuspensionRound Boston Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Kaufmann Pharma Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-8387-02 | May 19, 2027 | |
EliphorinCefalexin (as Monohydrate) | 500mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | EL Laboratories, Inc.Philippines | Trader: Elin Pharmaceuticals, Inc. | DRP-357 | Feb 16, 2028 | |
ExelCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)15 mL Amber Glass Bottle (10 mL net content) with medicine dropper (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-324 | Jan 28, 2030 | |
ExelCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-098 | Feb 1, 2030 | |
ExelCefalexin (as monohydrate) | 250 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-3557 | Sep 28, 2030 | |
ExelCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-096 | Nov 18, 2029 | |
ExelCefalexin (as monohydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-231 | Oct 29, 2030 | |
FalexCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle with Medicine Dropper x 30 mL (net content 15 mL) (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Zeutica, Inc. | DR-XY21437-B | Mar 3, 2030 | |
FalexCefalexin (as monohydrate) | 250 mg/5 mL Granules for SuspensionAmber Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Zeutica, Inc. | DR-XY19409-B | Jul 29, 2030 | |
FalexCefalexin (as monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Zeutica, Inc. | DR-XY21803-B | Apr 19, 2031 | |
Falteria 250Cefalexin (as monohydrate) | 250 mg CapsuleAlu/PVC Blister Pack x 10’s (Box of 100’s) | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-287 | Apr 16, 2029 | |
Falteria 500Cefalexin (as monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10’s Box of 100’s | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-288 | Apr 16, 2029 | |
FedlexinCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension for Oral DropsBoston Round Glass Bottle x 15 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Federal Pharmaceuticals Inc | DRP-12392-07 | Jul 21, 2027 | |
FedlexinCefalexin (as monohydrate) | 125 mg/ 5 mL Powder for SuspensionBoston Round Glass x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Federal Pharmaceuticals Inc. | DRP-12407-07 | Jul 21, 2027 | |
FedlexinCefalexin (as monohydrate) | 250 mg / 5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Federal Pharmaceuticals Inc. | DRP-12408-07 | Jul 21, 2027 | |
FlaximedCefalexin (As Monohydrate) | 100 mg/mL Powder For Suspension (Oral Drops)Amber Glass Bottle x 10 mL (Net Content) with Plastic Dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | CHMI Pharma, Inc. | DRP-130-05 | May 30, 2027 | |
FlaximedCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension (Strawberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | CHMI Pharma, Inc. | DRP-1426-12 | Feb 5, 2027 | |
FlaximedCefalexin (as monohydrate) | 500mg CapsuleAluminum Foil Strip x 10's (Box of 100's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: CHMI PHARMA, INC. | DR-XY18563 | Nov 11, 2028 | |
FleridineCefalexin (as monohydrate) | 500 mg CapsuleAluminum Strip Foil x 10's (Box of 100's) | Rx | Drugmakers Laboratories IncPhilippines | — | DRP-8047 | Jan 13, 2030 | |
ForexineCefalexin (As Monohydrate) | 500mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) Alu/Clear PVC Blister Pack x 10's + 1's (Box of 21's) | Rx | Hizon Laboratories, Inc.Philippines | Trader: GX International, Inc. | DR-XY40284 | Nov 16, 2026Past listed date | |
FulcefCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension | Rx | DIAMOND LABORATORIES INC. | FULL HEALTH INTERNATIONAL PHARMA | DRP-202-02 | Jan 17, 2027 | |
GifixCefalexin (as monohydrate) | 125mg/5mL Powder for Oral Suspension60 mL & 100 mL-capacity HDPE Bottle (Box of 1’s) | Rx | Globela Laboratories Private LimitedIndia | AMB HK Enterprises Inc. | DRP-18753 | Sep 3, 2031 | |
GifixCefalexin (as monohydrate) | 250mg/5mL Powder for Oral Suspension60 mL & 100 mL-capacity HDPE Bottle (Box of 1’s) | Rx | Globela Laboratories Private LimitedIndia | AMB HK Enterprises Inc. | DRP-18752 | Sep 3, 2031 | |
HalcepinCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)10 mL Net Content in 15 mL Boston Round Amber Bottle | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DR-XY16119-B | Mar 18, 2027 | |
HalcepinCefalexin (as Monohydrate) | 125 mg/5 mL Granules for Oral SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DR-XY17837-B | Oct 26, 2027 | |
HalcepinCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DRP-5783 | Jun 15, 2028 | |
HalcepinCefalexin (as Monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DR-XY18662-B | Oct 26, 2027 | |
Healthcare CefalexinCefalexin (as monohydrate) | 500 mg CapsuleAlu-Clear PVC Blister Pack x 21's (Box of 21's) | Rx | Lloyd Laboratories, Inc.Philippines | — | DR-XY39557 (For Export Only) | Jun 2, 2031 | |
InfexinCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle with Dropper x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DR-XY16805-B | Jul 27, 2027 | |
InfexinCefalexin (as monohydrate) | 125 mg/5 mL Granules for Oral SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DR-XY15314-B | Mar 20, 2027 | |
InfexinCefalexin (as monohydrate) | 250 mg/5 mL Granules for Suspension (Tutti-Frutti Flavor)Amber glass bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DR-XY16407-B | Jul 27, 2030 | |
InfexinCefalexin (as monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DR-XY15253-B | May 2, 2027 | |
ISEFCEFALEXIN (as monohydrate) | 125mg/5mL Powder for Oral Suspension60 mL HOPE Bottle with 10 mL measuring cup Box of 1's | Rx | Scott-Edi! Advance Research Laboratories & Education LimitedIndia | I.E MEDICA INC.Trader: I-Care Pharmaceuticals Pvt. Ltd | DRP-10070 | Oct 10, 2029 | |
ISEFCefalexin (as monohydrate) | 250 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL + 10 mL Measuring Cup (Box of 1's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | I.E MEDICA INC.Trader: I-Care Pharmaceuticals Pvt. Ltd | DRP-10071 | Sep 15, 2029 | |
KindoplexCefalexin (as monohydrate) | 100mg/mL Powder for Suspension (Oral Drops)Boston Round Amber Glass Bottle x 10mL Box of 1's | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DRP-7845 | Sep 27, 2027 | |
KindoplexCefalexin (as monohydrate) | 125mg/5mL Powder for SuspensionAmber glass bottle x 60mL Box of 1's | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DR-XY21737 | Aug 2, 2027 | |
KindoplexCefalexin (as monohydrate) | 500mg CapsuleAlu/Foil Strip x 10's Box of 100's | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DRP-8134 | May 29, 2027 | |
LemaflexCefalexin (as monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | JHISREH MEDICA CO., LTD. | DR-XY33377 | May 25, 2027 | |
LewimycinCefalexin (as monohydrate) | 100 mg / ml Powder for Suspension (Oral Drops)Amber Glass Bottle x 15 ml Box of 1's | Rx | NEW MYREX LABORATORIES, INC.Philippines | Trader: LEWISON PHARMACEUTICALS CORPORATION | DR-XY21725 | Aug 2, 2027 | |
LewimycinCefalexin (as monohydrate) | 250mg/5mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | Trader: Lewison Pharmaceuticals Corporation | DR-XY20985 | Feb 19, 2032 | |
LewimycinCefalexin (as monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | NEW MYREX LABORATORIES, INC.Philippines | Trader: LEWISON PHARMACEUTICALS CORPORATION | DRP-1271 | Aug 12, 2027 | |
LexibaseCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)10 mL Amber Glass Bottle with Dropper (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Basic Pharmaceutical Corp. | DR-XY17074-B | Jul 29, 2027 | |
LexibaseCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension60 mL Amber Glass Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Basic Pharmaceutical Corp. | DR-XY17073-B | Jul 29, 2027 | |
LexibaseCefalexin (as Monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Basic Pharmaceutical Corp. | DR-XY16945-B | Jul 29, 2027 | |
LexrielCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL with medicine dropper (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | 8th Green Care Pharma Inc.Trader: Transcend Phils., Inc. | DR-XY19099 | Sep 17, 2027 | |
LexrielCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Transcend Phils., Inc. | DR-XY18847 | Aug 25, 2027 | |
LexrielCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 60 mL N/A | Rx | Lloyd Laboratories, Inc.Bulacan | 8th Green Care Pharma Inc.Trader: Transcend Phils., Inc. | DR-XY18599 | Jan 30, 2032 | |
LexrielCefalexin (as Monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | 8th Green Care Pharma Inc.Trader: Transcend Phils., Inc. | DR-XY17893 | Sep 5, 2030 | |
LexzanCefalexin (as monohydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 50's and 100's) | Rx | Azarias Pharmaceutical Laboratories, Inc.Philippines | Triple 888 Medical and Pharma, Inc. | DRP-16453-04 | Apr 3, 2027 | |
LocefaCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)10 mL in 15 mL Amber Bottle (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | 999 Seth Pharmaceutical Inc. | DRP-1542-04 | Nov 21, 2031 | |
LocefaCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension (Strawberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories IncPhilippines | 999 Seth Pharmaceutical Inc. | DRP-1426-09 | Feb 5, 2027 | |
LonarelCefalexin (As Monohydrate) | 100 mg/mL Powder For Suspension (Oral Drops)Amber Glass Bottle X 10ml (Net Content) With Plastic Dropper (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | — | DRP-130 | May 30, 2027 | |
LonarelCefalexin (As Monohydrate) | 250 mg / 5 mL Powder for SuspensionAmber Bottle x 60 mL | Rx | J.M. Tolmann Laboratories Inc.Philippines | — | DRP-131 | Sep 8, 2030 | |
LonarelCefalexin (as monohydrate) | 500 mg CapsuleClear PVC/Alu Foil Blister Pack x 10's (Box of 100's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | — | DRP-132 | Aug 4, 2027 | |
LorecepCefalexin (as Monohydrate) | 100 mg/mL Granules for Suspension (Oral Drops)Amber Glass Bottle x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Philippine Home Pharmaceuticals | DR-XY19469 | Jan 5, 2030 | |
LorecepCefalexin (as monohydrate) | 250 mg/5 mL Powder for Suspension | Rx | Lloyd Laboratories, Inc. | Trader: Philippine Home Pharmaceutical | DR-XY19523 | Dec 22, 2026 | |
LorecepCefalexin (as Monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Philippine Home Pharmaceuticals | DR-XY19470 | Jan 6, 2030 | |
LyceplixCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Trader: Pharmacare Products Corporation | DR-XY33411 | Jun 4, 2029 | |
LyceplixCefalexin (as Monohydrate) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Trader: Pharmacare Products Corporation | DR-XY32378 | Oct 10, 2028 | |
LyceplixCefalexin (as monohydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's Box of 100's | Rx | J.M. Tolmann Laboratories Inc.Philippines | Trader: Pharmacare Products Corporation | DR-XY32645 | Nov 2, 2028 | |
MadexinCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Boston Round Amber Bottle x 10 mL (Box of 1's) | Rx | Sydenham Laboratories, Inc.Philippines | Trader: Medic + Aid Distributors, Inc. | DR-XY30633 | Jan 15, 2028 | |
MadexinCefalexin (as monohydrate) | 125 mg/5 mL Granules for Oral Suspension60 mL Amber Glass Bottle (Box of 1's) | Rx | Sydenham Laboratories, Inc.Philippines | Trader: Medic + Aid Distributors, Inc | DR-XY30632 | Jan 3, 2028 | |
MadexinCefalexin (as monohydrate) | 250 mg/5 mL Powder for Oral Suspension60 mL Amber Glass Bottle (Box of 1's) | Rx | Sydenham Laboratories, Inc.Philippines | Trader: Medic + Aid Distributors, Inc | DR-XY30641 | Jan 3, 2028 | |
MadexinCefalexin (as monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's Box of 100's | Rx | Sydenham Laboratories, Inc.Philippines | Trader: MEDIC+AID DISTRIBUTORS, INC | DR-XY30640 | Dec 12, 2027 | |
MedilexinCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL w/ dropper (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | Trader: IAE PHARMACEUTICAL CORPORATION | DR-XY33480 | Jun 14, 2027 | |
MedilexinCefalexin (as Monohydrate) | 500 mg CapsuleBlister Foil x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Trader: MB Bestmed OPC | DR-XY32326 | Sep 26, 2031 | |
MexinCefalexin (as monohydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | D.B. Manix International, Inc. | DRP-132-01 | Aug 4, 2027 | |
NerfalexCefalexin (as monohydrate) | 100 mg/mL Granules for Suspension (Oral Drops)15 mL Boston Round Amber Bottle x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Filadams Pharma, Inc.Trader: Generics Pharmacal Phils., Inc. | DR-XY17890 | Apr 15, 2027 | |
NerfalexCefalexin (as monohydrate) | 250 mg/5 mL Granules for oral SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Filadams Pharma, Inc.Trader: Generics Pharmacal Phils., Inc. | DR-XY17869 | Jul 12, 2027 | |
NerfalexCefalexin (as monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Filadams Pharma, Inc.Trader: Generics Pharmacal Phils., Inc. | DR-XY20480 | Oct 23, 2027 | |
Nerfalex DropsCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)10 mL in 15 mL Amber Bottle (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Generics Pharmacal Phils., Inc. | DRP-1542-07 | Nov 21, 2026 | |
NexefaCefalexin (as monhydrate) | 500 mg Capsule | Rx | Saga Lifesciences LimitedIndia | Hexagon Pharmaceuticals | DR-XY49643 | Feb 18, 2031 | |
NexeferCefalexin (as monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Hexagon Pharmaceuticals Limited | DRP-15886 | Sep 27, 2029 | |
NixinCefalexin (as monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Universal MBF Pharma (UMP), Co.Trader: Euro-Health Care Exponents, Inc. | DRP-9995-01 | Jul 6, 2031 | |
NoneCefalexin | 100 mg/mL Powder for Suspension (Oral Drops)Amber Bottle x 10 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: Ritemed Phils., Inc. | DR-XY26032 | Mar 15, 2031 | |
NoneCefalexin (as Monohydrate) | 100mg/mL Powder for Suspension (Oral drops)Boston Round Amber Glass Bottle x 10mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-7845-01 | Sep 27, 2027 | |
NoneCefalexin (as monohydrate) | 125 mg/5 mL Powder for Oral SuspensionAmber Glass Bottle with Aluminum Pilfer Proof Cap x 60 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Ritemed Phils., Inc.Trader: UNILAB, Inc. | DRP-9504-01 | Jun 17, 2031 | |
NoneCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionBoston Round Amber Bottle x 60 mL (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | FIRSTMED THERACONCEPT INC. | DRP-956-06 | Jan 12, 2029 | |
NoneCefalexin (as monohydrate) | 250 mg CapsuleAluminum flexible foil (front and back) x 4's (Box of 100's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: Ritemed Phils., Inc. | DR-XY26300 | Jun 2, 2031 | |
NoneCefalexin | 250 mg/ 5 mL Powder for SuspensionAmber Bottle x 60 mL (Box of 1's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: Ritemed Phils., Inc. | DR-XY26031 | Mar 15, 2031 | |
NoneCefalexin (as monohydrate) | 250 mg/5 mL Powder for Oral suspensionHDPE Bottle x 60 mL + 10 mL Measuring Cup Box of 1's | Rx | Scott-Edil Advance Research Laboratories & Education Limited.India | Medethix Inc.Importer: I.E. Medica Inc.Trader: I-Care Pharmaceuticals Pvt. Ltd. | DRP-10071-01 | Sep 15, 2029 | |
NoneCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Diamond Laboratories Inc.Philippines | — | DRP-7004 | Jul 11, 2027 | |
NoneCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension (Strawberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Firstmed Theraconcept Inc. | DRP-1426-10 | Feb 5, 2027 | |
NoneCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension (Strawberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Watsons Personal Care Stores (Philippines), Inc. | DRP-1426-14 | Feb 5, 2027 | |
NoneCefalexin (as Monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Hizon Laboratories, Inc.Philippines | Trader: Boie Incorporated | DR-XY16073 | Apr 4, 2027 | |
500 mg CapsuleAluminum foil strip x 4's (Box of 100's) | Rx | Lifesquare Laboratories Inc,Philippines | — | DRP-11693 | Apr 20, 2027 | ||
NoneCefalexin (as monohydrate) | 500 mg CapsuleAlu/Clear PVC Blister Pack x 10's Box of 100's | Rx | Centurion Remedies Pvt. Ltd.India | Watsons Personal Care Stores (Philippines), Inc.Importer: Philgen Pharmaceuticals Inc. | DRP-1997-03 | Oct 1, 2029 | |
NoneCefalexin (as monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10’s (Box of 100’s) | Rx | Brawn Laboratories LimitedIndia | ATC Healthcare International Corp.Importer: Ambica International Corporation | DRP-4436-01 | May 23, 2028 | |
NoneCefalexin (as monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | St. Joseph DrugstoreTrader: Innogen Pharmaceuticals, Inc. | DRP-7084-01 | May 23, 2027 | |
NoneCefalexin (as monohydrate) | 500 mg CapsuleBlister Pack x 10's Box of 100's | Rx | Lloyd Laboratories, Inc.Philippines | Dr. Zen’s Research, Inc.Trader: Innogen Pharmaceuticals, Inc. | DRP-7084-02 | May 23, 2027 | |
OneflexCefalexin (as monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | One Pharma Marketing Inc.Trader: Euro-Health Care Exponents, Inc. | DRP-9995-02 | Aug 14, 2030 | |
ParmecelCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Box of 10 mL in 15 mL Amber Bottle with dropper | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals Phils., Inc. | DR-XY19368 | Apr 11, 2027 | |
ParmecelCefalexin (as monohydrate) | 250 mg/5 mL Powder for Oral Suspension (Strawberry-Raspberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-1547 | Jun 24, 2027 | |
ParmecelCefalexin (as monohydrate) | 500 mg CapsuleAlu/Red PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-1548 | Aug 25, 2027 | |
Pediaflex ForteCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionPlastic Amber Bottle x 60 mL (Box of 1’s) | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-459 | Jan 3, 2028 | |
PneumonexCefalexin | 125 mg/5 mL Powder for Suspension (Cherry Flavor)Amber glass bottle x 60mL (Box of 1's) | Rx | Drugmakers Laboratories Inc.Philippines | — | DRP-5261 | Feb 7, 2037 | |
PneumonexCefalexin (as Monohydrate) | 500 mg CapsuleFoil Strip x 10's (Box of 100's) | Rx | Drugmaker's Laboratories Inc.Philippines | — | DRP-5814 | Sep 9, 2029 | |
ProfalexinCefalexin (as Monohydrate) | 100 mg/mL Granules for Suspension (Oral Drops)15 mL Amber Bottle with Plastic Dropper x 10 mL (Box of 10's) | Rx | Lloyd Laboratories, Inc.Philippines | Providencia Medica Inc.Trader: Foramen Products Corporation | DR-XY29403 | Jan 14, 2031 | |
ProfalexinCefalexin (as monohydrate) | 250mg/5mL Granules for SuspensionAmber glass bottle x 60mL (Box of 1's) | Rx | LLOYD LABORATORIES, INC.Philippines | Providencia Medica Inc.Trader: Foramen Products Corporation | DR-XY29366 | Feb 24, 2028 | |
ProfalexinCefalexin (as Monohydrate) | 500 mg CapsuleClear PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Providencia Medica Inc.Trader: Foramen Products Corporation | DR-XY29592 | May 12, 2031 | |
RapelexCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension for Oral DropsBoston Round Glass Bottle x 15 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc..Philippines | St.Raphael Archangel Pharmaceutical Product Distribution | DRP-12392-04 | Jul 21, 2027 | |
RapelexCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-12407-04 | Jul 21, 2027 | |
RapelexCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Rapael Archangel Pharmaceutical Product Distribution | DRP-12408-03 | Jul 21, 2027 | |
RaplexinCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension for Oral DropsBoston Round Glass Bottle x 15 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | St.Raphael Archangel Pharmaceutical Product Distribution | DRP-12392-05 | Jul 21, 2027 | |
RaplexinCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-12407-05 | Jul 21, 2027 | |
RaplexinCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-12408-06 | Jul 21, 2027 | |
RegilexinCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension for Oral DropsBoston Round Glass Bottle x 15 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-12392-03 | Jul 21, 2027 | |
RegilexinCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-12407-02 | Jul 21, 2027 | |
RegilexinCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionBoston Round Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-12408-02 | Jul 21, 2027 | |
RespinalCefalexin (as monohydrate) | 125 mg/5 mL Powder for SuspensionAmber Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Metz Pharmaceuticals, Inc. | DR-XY16471 | Aug 3, 2031 | |
RespinalCefalexin (as monohydrate) | 250 mg/5 mL Granules for SuspensionAmber Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Metz Pharmaceuticals, Inc. | DR-XY15964 | Nov 9, 2030 | |
RespinalCefalexin (as Monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Bulacan | Trader: Metz Pharmaceuticals, Inc. | DR-XY20166 | Aug 1, 2032 | |
500mg CapsuleAlu-PVC Blister x 10's (Box of 100's) | Rx | NGB Laboratories Pvt. Ltd.India | AMB HK Enterprises Inc. | DRP-11694 | Jun 9, 2028 | ||
Saphlexin-125Cefalexin (As Monohydrate) | 125 mg/5 mL Powder For Oral SuspensionRound Boston Amber Glass Bottle with measuring cup x 60 mL (Box of 1's) and Round Boston Amber Glass Botlte with measuring cup x 70 mL (Box of 1's) | Rx | Sunlovis Pharaceuticals LLPIndia | Nelpa Lifesciences, Inc. | DRP-18284 | Jun 8, 2031 | |
Saphlexin-250Cefalexin (as Monohydrate) | 250 mg/5 mL Powder for Oral SuspensionRound Boston Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Sapphire Lifesciences Pvt. Ltd.India | Importer: Nelpa Lifesciences, Inc. | DRP-8387 | May 19, 2027 | |
Saphlexin-C500Cefalexin (as monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | BUENO SALUD CARE INDIA PVT. LTD.India | NELPA LIFESCIENCES, INC.Trader: SAPPHIRE LIFESCIENCES PVT. LTD | DRP-4856 | Oct 24, 2028 | |
Saphlexin-ODCefalexin (as Monohydrate) | 100 mg per mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 15 mL (10 mL net content) (Box of 1's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Nelpa Lifesciences, Inc. | DRP-17649 | Feb 11, 2031 | |
SelzefCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)10 mL in 30 mL amber glass bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Heltker A.G. Corporation | DR-XY17609-B | May 10, 2027 | |
SelzefCefalexin (As Monohydrate) | 250 mg/5 mL Powder For SuspensionPlastic Bottle x 60 mL and 105 mL | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Heltker A.G. Corporation | DR-XY16472-B | May 10, 2027 | |
SelzefCefalexin (as monohydrate) | 500 mg CapsuleFoil Strip x 10's (Box of 21's and 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Heltker A.G. Corporation | DR-XY16597-B | May 10, 2027 | |
ThymexinCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension (Strawberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Thymed Enterprises | DRP-1426-11 | Feb 5, 2027 | |
ThymexinCefalexin (as monohydrate) | 500 mg CapsuleClear PVC/Alu Foil Blister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Thymed Enterprises | DRP-132-11 | Aug 4, 2027 | |
TonnaxeCefalexin (As Monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)15 mL (Net Content) In 30 mL Boston Round Amber Bottle with printed Aluminum Cap (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Trader: Apt Drugs Trading | DR-XY30965 | Aug 5, 2030 | |
TonnaxeCefalexin (As Monohydrate) | 250 mg / 5 mL Powder for SuspensionBoston Round Bottle X 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Trader: APT Drugs Trading | DR-XY30960 | Aug 5, 2030 | |
TonnaxeCefalexin (As Monohydrate) | 500 mg CapsuleBlister Pack X 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Trader: Apt Drugs Trading | DR-XY30964 | Aug 5, 2030 | |
UnbrandedCefalexin (as monohydrate) | 500 mg CapsuleAluminum flexible foil (front and back) x 4's (Box of 100's); Aluminum flexible foil (front and back) x 4's Compliance Pack (Box of 21's) | Rx | Asian Antibiotics, Inc.Philippines | Trader: Ritemed Phils., Inc. | DR-XY26299 | Jun 2, 2031 | |
VicephrinCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vitalink Health Products, Inc. | DRP-8288 | Jan 22, 2030 | |
VicephrinCefalexin (as Monohydrate) | 125 mg/mL Powder for SuspensionAmber Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vitalink Health Products, Inc. | DR-XY18199-B | May 23, 2031 | |
VicephrinCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionAmber Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Vitalink Health Products, Inc. | DRP-8308 | May 23, 2030 | |
VinlexinCefalexin (as monohydrate) | 250 mg/5 mL Powder for Oral Suspension (Strawberry-Raspberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Vincare PharmaTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-1547-02 | Jun 24, 2027 | |
VinlexinCefalexin (as monohydrate) | 500 mg CapsuleAlu/Red PVC Blister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Vincare PharmaTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-1548-02 | Aug 25, 2027 | |
WINACEFCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)10 mL in 15 mL Amber bottle with medicine dropper Box of 1's | Rx | J.M. TOLMANN LABORATORIES, INC.METRO MANILA | — | DRP-1542 | Nov 21, 2031 | |
WINACEFCefalexin (As Monohydrate) | 125 mg/5 mL Powder for SuspensionBoston Round Amber Bottle x 60mL (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | — | DRP-956 | Jan 12, 2029 | |
WinacefCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension (Strawberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Metro Manila | — | DRP-1426 | Feb 5, 2032 | |
WinacefCefalexin | 500 mg CapsuleBlister Pack X 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | — | DRP-10545 | Mar 6, 2031 | |
XelaresCefalexin (as Monohydrate) | 250 mg/5 mL Powder for Suspension (Strawberry Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Medirich Pharma Distribution Corp. | DRP-1426-13 | Feb 5, 2027 | |
XelaresCefalexin | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | J.M. Tolmann Laboratories IncPhilippines | Medirich Pharma Distribution Corp | DRP-10545-01 | May 19, 2031 | |
XinflexCefalexin (as Monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass Bottle x 10 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: Terramedic, Inc. | DR-XY22421 | Jan 9, 2027 | |
XinflexCefalexin (as Monohydrate) | 250 mg/ 5 mL Powder for Suspension60 mL and 70 mL net content in 120 mL capacity Amber Glass Bottle Box of 1's | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: Terramedic, Inc. | DR-XY21615 | Jul 15, 2027 | |
XinflexCefalexin (as Monohydrate) | 500 mg CapsuleFoil Strip x 10's (Box of 100's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: Terramedic, Inc. | DR-XY21851 | Sep 2, 2027 | |
ZefalexCefalexin (as monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's Box of 100's | Rx | Centurion Remedies Pvt. Ltd.India | Meedpharma Medical Supplies & Equipment DistributorImporter: Philgen Pharmaceuticals Inc. | DRP-1997 | Oct 1, 2029 | |
ZeporinCefalexin (as monohydrate) | 100 mg/mL Powder for Suspension (Oral Drops)Amber Glass bottle with dropper x 10 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: Pharma Dynamic, Inc. | DR-XY14978 | Feb 18, 2029 | |
ZeporinCefalexin (as monohydrate) | 250 mg/5 mL Powder for SuspensionAmber Bottle with Aluminum Cap x 120 mL (60 mL net content) (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Pharma Dynamic, Inc. | DR-XY14979 | Feb 3, 2030 | |
ZeporinCefalexin (as monohydrate) | 500 mg CapsuleFoil strip x 10's (Box of 50's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: Pharma Dynamic, Inc. | DR-XY21637 | Jul 17, 2031 | |
(no brand name)Cefalexin (as monohydrate) | 500 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Medico Remedies Limited | I.E. Medica Inc.Importer: MedEthix, Inc. | DRP-18505 | Jul 22, 2031 | |
(no brand name)Cefalexin (as monohydrate) | 500 mg CapsuleBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Actimed, Inc.Trader: Innogen Pharmaceuticals, Inc. | DRP-7084 | May 23, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
WARNINGS Hypersensitivity Reactions Allergic reactions in the form of rash, urticaria, angioedema, anaphylaxis, erythema multiforme, Stevens-Johnson syndrome, or toxic epidermal necrolysis have been reported with the use of cephalexin tablets. Before therapy with cephalexin tablets are instituted, inquire whether the patient has a history of hypersensitivity reactions to cephalexin, cephalosporins, penicillins, or other drugs.
Cross-hypersensitivity among beta-lactam antibacterial drugs may occur in up to 10% of patients with a history of penicillin allergy. If an allergic reaction to cephalexin tablets occurs, discontinue the drug and institute appropriate treatment. Clostridium difficile-A ssociated Diarrhea Clostridium difficile-a ssociated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including cephalexin tablets, and may range in severity from mild diarrhea to fatal colitis.
Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile. C. difficile produces toxins A and B, which contribute to the development of CDAD. Hypertoxin-producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy.
CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued.
Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated Direct Coomb’s Test Seroconversion Positive direct Coombs tests have been reported during treatment with the cephalosporin antibacterial drugs including cephalexin. Acute intravascular hemolysis induced by cephalexin therapy has been reported.
If anemia develops during or after cephalexin therapy, perform a diagnostic work-up for drug-induced hemolytic anemia, discontinue cephalexin and institute appropriate therapy. Seizure Potential Several cephalosporins have been implicated in triggering seizures, particularly in patients with renal impairment when the dosage was not reduced.
If seizures occur, discontinue cephalexin tablets. Anticonvulsant therapy can be given if clinically indicated. Prolonged Prothrombin Time Cephalosporins may be associated with prolonged prothrombin time. Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antibacterial therapy, and patients receiving anticoagulant therapy.
Monitor prothrombin time in patients at risk and manage as indicated.
Drug interactions
| Drug or class | Severity | Effect | What to do |
|---|---|---|---|
| Metformin | Adjust or monitor | Higher metformin levels; lower metformin renal clearance (label). | Monitor; adjust metformin dose. |
| Probenecid | Avoid | Blocks tubular secretion; higher and longer drug levels (label). | Coadministration not recommended. |
Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.
renalcarematters.com, reviewedDrug interactions (US label) US FDA label
DRUG INTERACTIONS Metformin: Administration of cephalexin tablets with metformin results in increased plasma metformin concentrations and decreased renal clearance of metformin. Careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin tablets and metformin[see CLINICAL PHARMACOLOGY].
Probenecid: The renal excretion of cephalexin tablets is inhibited by probenecid. Co-administration of probenecid with cephalexin tablets is not recommended. Drug/laboratory Test Interactions: A false-positive reaction may occur when testing for the presence of glucose in the urine using Benedict's solution or Fehling's solutions.
Adverse reactions
Common
- Diarrhea
- Nausea, vomiting, dyspepsia, abdominal pain
Serious
- Anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis
- Clostridioides difficile-associated diarrhea
- Seizures in kidney impairment without dose reduction
Adverse reactions (US label) US FDA label
ADVERSE REACTIONS Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The most frequent adverse reaction was diarrhea.
Nausea and vomiting, dyspepsia, gastritis, and abdominal pain have also occurred. As with penicillins and other cephalosporins, transient hepatitis and cholestatic jaundice have been reported. Other reactions have included hypersensitivity reactions, genital and anal pruritus, genital candidiasis, vaginitis and vaginal discharge, dizziness, fatigue, headache, agitation, confusion, hallucinations, arthralgia, arthritis, and joint disorder.
Reversible interstitial nephritis has been reported. Eosinophilia, neutropenia, thrombocytopenia, hemolytic anemia, and slight elevations in aspartate transaminase (AST) and alanine transaminase (ALT) have been reported. In addition to the adverse reactions listed above that have been observed in patients treated with cephalexin tablets, the following adverse reactions and other altered laboratory tests have been reported for cephalosporin class antibacterial drugs: Other Adverse Reactions: Fever, colitis, aplastic anemia, hemorrhage, renal dysfunction, and toxic nephropathy.
Altered Laboratory Tests: Prolonged prothrombin time, increased blood urea nitrogen (BUN), increased creatinine, elevated alkaline phosphatase, elevated bilirubin, elevated lactate dehydrogenase (LDH), pancytopenia, leukopenia, and agranulocytosis.
Monitoring parameters
- CrCl for dose; seizures with unadjusted doses in kidney impairment (label precautions); metformin levels if coadministered; diarrhea (CDAD). Kidney
- CrCl for dose
- Glucose control if on metformin
Pregnancy considerations
Pregnancy (US label) US FDA label
PREGNANCY Reproduction studies have been performed on mice and rats using oral doses of cephalexin monohydrate 0.6 and 1.5 times the maximum daily human dose (66 mg/kg/day) based upon body surface area basis and have revealed no evidence of impaired fertility or harm to the fetus. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
Breastfeeding considerations
Lactation (US label) US FDA label
NURSING MOTHERS Cephalexin is excreted in human milk. Caution should be exercised when cephalexin tablets are administered to a nursing woman.
Pharmacokinetics
Key PK parameters
| Time to peak | About 9, 18 and 32 mcg/mL at 1 hour after 250 mg, 500 mg and 1 g |
|---|---|
| Protein binding | 10% to 15% |
| Renal excretion kidney | Over 90% unchanged in urine within 8 hours (filtration and tubular secretion) |
| Dialyzability kidney | Not established (label) |
Cephalexin is excreted in the urine by glomerular filtration and tubular secretion.
Studies showed that over 90% of the drug was excreted unchanged in the urine within 8 hours.
In healthy subjects given single 500 mg doses of cephalexin and metformin, plasma metformin mean C max and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%.
Pharmacokinetics (US label) US FDA label
CLINICAL PHARMACOLOGY Human Pharmacology Cephalexin tablets are acid stable and may be given without regard to meals. It is rapidly absorbed after oral administration. Following doses of 250 mg, 500 mg, and 1g, average peak serum levels of approximately 9, 18, and 32 mcg/mL, respectively, were obtained at 1 hour. Serum levels were detectable 6 hours after administration (at a level of detection of 0.2 mcg/mL).
Cephalexin is approximately 10% to 15% bound to plasma proteins. Cephalexin is excreted in the urine by glomerular filtration and tubular secretion. Studies showed that over 90% of the drug was excreted unchanged in the urine within 8 hours. During this period, peak urine concentrations following the 250-mg, 500-mg, and 1-g doses were approximately 1000, 2200, and 5000 mcg/mL, respectively.
In healthy subjects given single 500 mg doses of cephalexin and metformin, plasma metformin mean C max and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%. No information is available about the interaction of cephalexin and metformin following multiple doses of either drug.
Microbiology Cephalexin is a bactericidal agent that acts by the inhibition of cell-wall synthesis. Resistance -Methicillin-resistant staphylococci and most isolates of enterococci are resistant to cephalexin. Cephalexin is not active against most isolates of Enterobacter spp., Morganella morganii, and Proteus vulqaris. Cephalexin has no activity against Pseudomonas spp., or Acinetobacter calcoaceticus.
Penicillinresistant Streptococcus pneumoniae is usually cross-resistant to beta-lactam antibacterial drugs. Antimicrobial Activity - Cephalexin is active against most isolates of the following bacteria both in vitro and in clinical infections [see INDICATIONS and USAGE]: Gram-positive bacteria Staphylococci aureus (methicillin-susceptible isolates only), Streptococcus pneumoniae (penicillin-susceptible isolates) Streptococcus pyogenes Gram-negative bacteria Escherichia coli Haemophilus influenzae Klebsiella pneumoniae Moraxella catarrhalis Proteus mirabilis Susceptibility Testing- For specific information regarding susceptibility test interpretive criteria and associated test methods and quality control standards recognized by FDA for this drug, please see: https://www.fda.gov/STIC.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Cefalexin 100 mg/mL, 10 mL Drops | ₱14.95–₱24.80Reference ₱18.00 | per unit | DPRI procurement range |
| Cefalexin 250 mg/5 mL, 60 mL Bottle | ₱22.00–₱60.20Reference ₱25.93 | per bottle | DPRI procurement range |
| Cefalexin 500 mg Capsule | ₱1.57–₱9.50Reference ₱2.65 | per capsule | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Cefalexin (as monohydrate) |
| PNF listing | Oral: 500 mg capsule |
| PNF listing | Oral: 100 mg/mL, granules/powder for drops, 10 mL |
| PNF listing | Oral: 125 mg/5 mL granules/powder for syrup/suspension, 30 mL |
| PNF listing | Oral: 250 mg/5 mL granules/powder for syrup/suspension, 60 mL |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Cephalexin · Ascend Laboratories, LLC [US FDA-approved label, version 4, October 16, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=36882c6d-7b6f-41e3-8c54-e3b0073b8c07
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
- Ascend Laboratories, LLC. (2026). Cephalexin tablets, USP [Prescribing information; US FDA-approved label, ANDA218947, set ID 36882c6d-7b6f-41e3-8c54-e3b0073b8c07, version effective October 16, 2026]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=36882c6d-7b6f-41e3-8c54-e3b0073b8c07
renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.
Last updated: .

